Opportunity Information: Apply for CDC RFA GH15 16150301SUPP17
The Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM-PHACTS) is a PEPFAR-aligned cooperative agreement run through the U.S. Centers for Disease Control and Prevention (CDC), Center for Global Health, designed to strengthen Namibia's ability to deliver and sustain high-quality HIV and related public health services. The core idea is not to fund a new organization to run clinics directly, but to fund targeted technical assistance, capacity building, and specialized implementation support that helps the Government of the Republic of Namibia and its implementing partners improve performance, expand coverage, and maintain quality as programs scale. It is explicitly meant to reinforce PEPFAR- and Global Fund-supported activities, with HIV as the main emphasis, while allowing support to broader global health functions when they are necessary to make HIV services work.
The opportunity focuses on five technical program areas that are central to epidemic control and health-system performance: Prevention of Mother-to-Child Transmission of HIV (PMTCT); HIV care and treatment clinical services for adults and children; pediatric HIV care and treatment; surveillance and strategic information (SI); and laboratory systems. In practical terms, these areas cover everything from improving antenatal and maternal HIV services and keeping mothers and infants in care, to strengthening adult and pediatric ART services, to ensuring data systems are reliable enough to guide decisions, and making sure lab networks can support testing and monitoring (including the quality and timeliness of results). A related aim is to help Global Fund implementing partners assess HIV service delivery and develop technical assistance plans and strategies based on those findings, so that gaps in quality, coverage, or systems can be addressed quickly and in a coordinated way.
A defining feature of this particular notice is that it is a supplemental award with restricted eligibility. The only eligible entity is the University of Washington's International Education and Training Center for Health (I-TECH). CDC justifies this limitation by pointing to I-TECH's long-standing integration into Namibia's Ministry of Health and Social Services (MOHSS) service delivery environment and its existing ability to provide both clinical mentorship and technical assistance directly inside MOHSS facilities. I-TECH has supported Namibia since 2002 across major HIV service domains such as antiretroviral therapy scale-up, management of opportunistic infections, HIV testing and counseling, early infant diagnosis, voluntary medical male circumcision, PMTCT, and pediatric disclosure programming. Importantly, I-TECH operates under a memorandum of understanding with MOHSS (first signed in 2010) that allows it to place clinical mentors and additional staff to work alongside government staff within MOHSS facilities; the notice argues that other partners do not have comparable operational access or the same degree of embedded collaboration required to execute the expansion quickly.
The supplement is tied to an existing CDC award scope (referenced as CDC-RFA-GH15-1615, Program Area B) that already includes key activities like helping MOHSS plan and implement a national clinical mentoring program, supporting regions to conduct routine reviews of program data and performance, and providing technical assistance and implementation support for newer service delivery models aligned with combination prevention. The proposed expansion is presented as consistent with that approved scope of work, but scaled to meet emerging priorities and more ambitious targets. Two specific near-term priorities are highlighted: expanding technical assistance and service delivery support in the Kavango and Khomas regions to advance epidemic control goals, and implementing the VACS survey in Namibia (noted as a major survey effort that MOHSS is not currently equipped to deliver at the required scale). Because of the urgency, the CDC notes there was not enough time to run a full competitive process and still start activities by the operational deadline.
From an administrative standpoint, the opportunity is a discretionary cooperative agreement (meaning CDC is expected to have substantial involvement in guiding or coordinating the work rather than simply issuing a hands-off grant). It is listed under CFDA 93.067, with an expected single award, and an award ceiling of $2,969,692. The funding opportunity number is CDC RFA GH15 16150301SUPP17, with an original closing date of November 20, 2017, and a creation date of September 21, 2017. The timeline is a major driver: the notice states that clinical service delivery support and the VACS survey work needed to begin by October 1, 2017, and that because I-TECH operates on an April 1 award cycle, supplemental funds were needed by October 1 to launch the expansion on schedule.
Overall, NAM-PHACTS is structured as a mechanism to rapidly strengthen Namibia's HIV response by improving the technical quality, workforce capability, data use, and laboratory backbone that PEPFAR and Global Fund programs rely on. The rationale for a single eligible applicant is that I-TECH is already embedded in MOHSS systems, already authorized through an MOU to operate within government facilities, and already performing related tasks under an active CDC award. The notice also makes clear what is at stake: without the supplement, Namibia and I-TECH would not be able to expand into priority regions or implement the large-scale survey work in time, which could jeopardize meeting increased PEPFAR COP17 targets and slow progress toward epidemic control.Apply for CDC RFA GH15 16150301SUPP17
- The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM-PHACTS) under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on 2017-09-21.
- Applicants must submit their applications by 2017-11-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $2,969,692.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support (NAM-PHACTS)?
NAM-PHACTS is a PEPFAR-aligned cooperative agreement run through the U.S. Centers for Disease Control and Prevention (CDC), Center for Global Health. It is designed to strengthen Namibia's ability to deliver and sustain high-quality HIV and related public health services by providing targeted technical assistance, capacity building, and specialized implementation support.
What is the main goal of NAM-PHACTS?
The main goal is to reinforce and improve the performance, coverage, and quality of HIV services in Namibia by strengthening the systems and workforce that deliver those services. The mechanism is meant to help the Government of the Republic of Namibia and its implementing partners improve results as programs scale.
Is this opportunity intended to fund a new organization to run clinics directly?
No. The intent is not to fund a new organization to directly operate clinics. The focus is on technical assistance, capacity building, and specialized implementation support that helps government and partners deliver better services within existing systems.
How does NAM-PHACTS relate to PEPFAR and the Global Fund?
It is explicitly meant to reinforce PEPFAR- and Global Fund-supported activities. HIV is the main emphasis, and support to broader global health functions is included when those functions are necessary to make HIV services work effectively.
What are the technical program areas supported under this opportunity?
The opportunity focuses on five technical program areas: Prevention of Mother-to-Child Transmission of HIV (PMTCT); HIV care and treatment clinical services for adults and children; pediatric HIV care and treatment; surveillance and strategic information (SI); and laboratory systems.
What kinds of activities are included under PMTCT support?
Based on the description, PMTCT support includes strengthening antenatal and maternal HIV services and improving retention in care for mothers and infants to sustain effective prevention of mother-to-child transmission outcomes.
What does support for adult and pediatric HIV care and treatment involve?
In practical terms, it involves strengthening clinical service delivery for antiretroviral therapy (ART) for adults and children, improving quality of care, and supporting service delivery models that help programs expand coverage while maintaining performance.
What is meant by surveillance and strategic information (SI) in this opportunity?
Surveillance and strategic information refers to strengthening data systems and data use so information is reliable enough to guide decisions. This includes supporting routine reviews of program data and performance as part of improving service delivery and meeting targets.
What does laboratory systems support cover?
Laboratory systems support is described as strengthening lab networks so they can support HIV testing and monitoring, including improving the quality and timeliness of results that clinical programs depend on.
How does this opportunity support Global Fund implementing partners?
A related aim is to help Global Fund implementing partners assess HIV service delivery and develop technical assistance plans and strategies based on those findings, so gaps in quality, coverage, or systems can be addressed quickly and in a coordinated way.
Is this a new award or a supplement to an existing award?
This notice is for a supplemental award tied to an existing CDC award scope referenced as CDC-RFA-GH15-1615 (Program Area B). The expansion is presented as consistent with the already approved scope of work, but scaled up to meet emerging priorities and more ambitious targets.
What is the funding opportunity number for this supplement?
The funding opportunity number is CDC RFA GH15 16150301SUPP17.
What CFDA number is associated with this opportunity?
The opportunity is listed under CFDA 93.067.
What type of award mechanism is NAM-PHACTS under this notice?
It is a discretionary cooperative agreement, meaning CDC is expected to have substantial involvement in guiding or coordinating the work rather than issuing a hands-off grant.
How many awards does CDC expect to make under this notice?
The notice indicates an expected single award.
What is the award ceiling for this opportunity?
The award ceiling is $2,969,692.
Who is eligible to apply for this supplemental award?
Eligibility is restricted. The only eligible entity listed is the University of Washington's International Education and Training Center for Health (I-TECH).
Why is eligibility restricted to only I-TECH?
CDC justifies the restriction by citing I-TECH's long-standing integration into Namibia's Ministry of Health and Social Services (MOHSS) service delivery environment and its ability to provide clinical mentorship and technical assistance directly inside MOHSS facilities. The notice argues that other partners do not have comparable operational access or the same degree of embedded collaboration required to execute the expansion quickly.
What is I-TECH's history of HIV support in Namibia as described in the notice?
The notice states I-TECH has supported Namibia since 2002 across major HIV service domains including ART scale-up, management of opportunistic infections, HIV testing and counseling, early infant diagnosis, voluntary medical male circumcision, PMTCT, and pediatric disclosure programming.
How is I-TECH able to work inside MOHSS facilities?
I-TECH operates under a memorandum of understanding (MOU) with MOHSS, first signed in 2010, which allows I-TECH to place clinical mentors and additional staff to work alongside government staff within MOHSS facilities.
What existing activities are referenced as part of the underlying CDC award scope?
The referenced scope includes helping MOHSS plan and implement a national clinical mentoring program, supporting regions to conduct routine reviews of program data and performance, and providing technical assistance and implementation support for newer service delivery models aligned with combination prevention.
What near-term priorities are highlighted for this supplemental expansion?
Two specific near-term priorities are highlighted: expanding technical assistance and service delivery support in the Kavango and Khomas regions to advance epidemic control goals, and implementing the VACS survey in Namibia.
Which regions in Namibia are specifically mentioned for expanded support?
The notice specifically mentions the Kavango and Khomas regions as priority areas for expanded technical assistance and service delivery support.
What is the VACS survey in the context of this opportunity?
The notice describes the VACS survey as a major survey effort that MOHSS is not currently equipped to deliver at the required scale, and identifies implementation of the survey as a priority activity under the supplement.
Why was a full competitive process not used for this award?
The notice cites urgency and timing constraints, stating there was not enough time to run a full competitive process and still start activities by the operational deadline.
What were the key dates listed in the notice?
The creation date is September 21, 2017. The original closing date is November 20, 2017. The notice also states work needed to begin by October 1, 2017.
Why was October 1, 2017 emphasized as an operational deadline?
The notice states that clinical service delivery support and the VACS survey work needed to begin by October 1, 2017, and that supplemental funds were needed by that date to launch the expansion on schedule.
How does I-TECH's award cycle affect the need for supplemental funds?
The notice explains that I-TECH operates on an April 1 award cycle, so supplemental funds were needed by October 1 to support a mid-cycle expansion and ensure activities could start on time.
What is the overall purpose of the supplement as described?
The supplement is structured to rapidly strengthen Namibia's HIV response by improving technical quality, workforce capability, data use, and the laboratory backbone that PEPFAR and Global Fund programs rely on, particularly in priority regions and for large-scale survey implementation.
What could happen if the supplement was not provided, according to the notice?
The notice states that without the supplement, Namibia and I-TECH would not be able to expand into priority regions or implement the large-scale survey work in time, which could jeopardize meeting increased PEPFAR COP17 targets and slow progress toward epidemic control.
Does this opportunity allow support beyond HIV services?
Yes, but with a condition. The notice emphasizes HIV as the main focus while allowing support to broader global health functions when those functions are necessary to make HIV services work.
Browse more opportunities from the same category: Health
Next opportunity: Roadmap to Rebuild, Modernize, and Decarbonize the Ukraine Steel Industry with Secure and Safe Small Modular Reactors (SMR)
Previous opportunity: U.S.-Brazil Binational Centers’ (BNCs) Faculty Development Exchange
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 16150301SUPP17
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 16150301SUPP17) also looked into and applied for these:
| Funding Opportunity |
|---|
| Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation Apply for CDC RFA CK20 2001 Funding Number: CDC RFA CK20 2001 Agency: Centers for Disease Control - NCEZID Category: Health Funding Amount: $100,000 |
| USAID/Uganda Local Service Delivery for HIV/AIDS Activity Apply for 72061720RFA00002 Funding Number: 72061720RFA00002 Agency: Uganda USAID-Kampala Category: Health Funding Amount: $50,000,000 |
| NIA Research Centers Collaborative Network (RCCN) (U24 Clinical Trial Optional) Apply for RFA AG 21 001 Funding Number: RFA AG 21 001 Agency: National Institutes of Health Category: Health Funding Amount: $675,000 |
| Drug-Free Communities (DFC) Support Program – Non-competing Continuation Apply for CDC RFA CE20 2004 Funding Number: CDC RFA CE20 2004 Agency: Centers for Disease Control - NCIPC Category: Health Funding Amount: $125,000 |
| Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed) Apply for RFA HL 21 018 Funding Number: RFA HL 21 018 Agency: National Institutes of Health Category: Health Funding Amount: $485,000 |
| PEPFAR Grants for Community-Led Monitoring Apply for DOS NG PEPFARCLM FY2022 001 Funding Number: DOS NG PEPFARCLM FY2022 001 Agency: U.S. Mission to Nigeria Category: Health Funding Amount: $25,000 |
| Life Course Translational Research Network (LCT-RN) Apply for HRSA 23 083 Funding Number: HRSA 23 083 Agency: Health Resources and Services Administration Category: Health Funding Amount: $800,000 |
| Advancing Health Equity in Asthma Control through EXHALE Strategies Apply for CDC RFA EH 24 0016 Funding Number: CDC RFA EH 24 0016 Agency: Centers for Disease Control - NCEH Category: Health Funding Amount: $725,000 |
| Children, Adolescents, and Families in the HIV Epidemic in North West Province Apply for 72067423RFA00012 Funding Number: 72067423RFA00012 Agency: South Africa USAID-Pretoria Category: Health Funding Amount: $20,000,000 |
| Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) Apply for CDC RFA CK 24 0002 Funding Number: CDC RFA CK 24 0002 Agency: Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Implementation of Community Health Worker-Mediated Services for Re-Engagement to Care and Outreach for Persons with HIV in Rural Communities (REACH: Rural Re-Engagement and Care using CHWs for Persons with HIV) Apply for CDC RFA PS 24 0026 Funding Number: CDC RFA PS 24 0026 Agency: Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Epidemiologic Cohort Study of Interstitial Cystitis Apply for RFA DP 24 031 Funding Number: RFA DP 24 031 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $900,000 |
| Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations in Community Health Settings Apply for RFA DP 24 081 Funding Number: RFA DP 24 081 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $950,000 |
| Native Hawaiian Health Care Improvement Act Program Apply for HRSA 24 030 Funding Number: HRSA 24 030 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Regional AIDS Education and Training Centers Apply for HRSA 24 059 Funding Number: HRSA 24 059 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Linking Eligibility Across the Ryan White HIV/AIDS Program Parts - Dissemination Assistance Provider Apply for HRSA 24 057 Funding Number: HRSA 24 057 Agency: Health Resources and Services Administration Category: Health Funding Amount: $2,000,000 |
| Ryan White HIV/AIDS Program Part D - Women, Infants, Children and Youth (WICY) Grant Supplemental Funding Apply for HRSA 24 061 Funding Number: HRSA 24 061 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part F Dental Reimbursement Program (DRP) Apply for HRSA 24 060 Funding Number: HRSA 24 060 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Fiscal Year 2024 Behavioral Health Service Expansion Apply for HRSA 24 078 Funding Number: HRSA 24 078 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Supporting People with HIV as Leaders in HIV Systems of Care Apply for HRSA 24 055 Funding Number: HRSA 24 055 Agency: Health Resources and Services Administration Category: Health Funding Amount: $800,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 16150301SUPP17", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.